Allworth Financial’s Tenax Therapeutics TENX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $15 | Hold |
1
| – | – | ﹤0.01% | 5116 |
|
|
2026
Q1 | $16 | Hold |
1
| – | – | ﹤0.01% | 5143 |
|
|
2025
Q4 | $13 | Hold |
1
| – | – | ﹤0.01% | 4944 |
|
|
2025
Q3 | $8 | Hold |
1
| – | – | ﹤0.01% | 4881 |
|
|
2025
Q2 | $6 | Hold |
1
| – | – | ﹤0.01% | 4567 |
|
|
2025
Q1 | $6 | Hold |
1
| – | – | ﹤0.01% | 4034 |
|
|
2024
Q4 | $7 | Hold |
1
| – | – | ﹤0.01% | 3916 |
|
|
2024
Q3 | $4 | Hold |
1
| – | – | ﹤0.01% | 3729 |
|
|
2024
Q2 | $4 | Hold |
1
| – | – | ﹤0.01% | 3674 |
|
|
2024
Q1 | $5 | Buy |
+1
| New | +$8 | ﹤0.01% | 3579 |
|
|
2023
Q4 | – | Hold |
0
| – | -$1 | – | 3617 |
|
|
2023
Q3 | – | Hold |
0
| – | – | – | 3430 |
|
|
2023
Q2 | – | Hold |
0
| – | – | – | 3246 |
|
|
2023
Q1 | – | Hold |
0
| – | – | – | 3180 |
|
|
2022
Q4 | – | Hold |
0
| – | – | – | 3191 |
|
|
2022
Q3 | – | Hold |
0
| – | – | – | 3098 |
|
|
2022
Q2 | – | Hold |
0
| – | – | – | 2806 |
|
|
2022
Q1 | – | Hold |
0
| – | – | – | 2378 |
|
|
2021
Q4 | – | Hold |
0
| – | – | – | 2116 |
|
|
2021
Q3 | – | Hold |
0
| – | – | – | 1973 |
|
|
2021
Q2 | – | Hold |
0
| – | – | – | 1660 |
|
|
2021
Q1 | – | Hold |
0
| – | – | – | 1616 |
|
|
2020
Q4 | – | Hold |
0
| – | – | – | 1437 |
|
|
2020
Q3 | – | Hold |
0
| – | – | – | 1265 |
|
|
2020
Q2 | – | Hold |
0
| – | – | – | 1364 |
|
|
2020
Q1 | – | Hold |
0
| – | – | – | 1326 |
|
|
2019
Q4 | – | Hold |
0
| – | – | – | 1108 |
|
|
2019
Q3 | – | Hold |
0
| – | – | – | 1014 |
|
|
2019
Q2 | – | Hold |
0
| – | – | – | 1036 |
|
|
2019
Q1 | – | Hold |
0
| – | – | – | 1031 |
|
|
2018
Q4 | – | Hold |
0
| – | – | – | 938 |
|
|
2018
Q3 | – | Hold |
0
| – | – | – | 989 |
|
|
2018
Q2 | – | Hold |
0
| – | – | – | 1012 |
|
|
2018
Q1 | – | Hold |
0
| – | – | – | 872 |
|
|
2017
Q4 | – | Hold |
0
| – | – | – | 817 |
|
|
2017
Q3 | – | Hold |
0
| – | – | – | 800 |
|
|
2017
Q2 | – | Hold |
0
| – | – | – | 821 |
|
|
2017
Q1 | – | Hold |
0
| – | – | – | 817 |
|
|
2016
Q4 | – | Hold |
0
| – | – | – | 738 |
|
|
2016
Q3 | – | Hold |
0
| – | – | – | 739 |
|
|
2016
Q2 | – | Hold |
0
| – | – | – | 675 |
|
|
2016
Q1 | – | Hold |
0
| – | – | – | 663 |
|
|
2015
Q4 | – | Hold |
0
| – | – | – | 659 |
|
|
2015
Q3 | – | Hold |
0
| – | – | – | 642 |
|
|
2015
Q2 | – | Hold |
0
| – | – | – | 633 |
|
|
2015
Q1 | – | Hold |
0
| – | – | – | 623 |
|
Other funds holding TENX
VC
PA
IC
CS
RI
Allworth Financial's TENX Position: Q2 2026 in Review
Allworth Financial held its Tenax Therapeutics (TENX) position steady in Q2 2026 at 1 share worth $15. The position accounts for ﹤0.01% of the portfolio, ranked #5116.
Allworth Financial first reported a position in TENX in Q1 2024 and has held it in 10 quarters since. The position peaked at $16 in Q1 2026. 111 funds tracked by Wall St. Rank hold TENX as of Q2 2026.
- Allworth Financial held 1 share of Tenax Therapeutics worth $15 as of Q2 2026.
- Allworth Financial left its Tenax Therapeutics share count unchanged in Q2 2026.
- Tenax Therapeutics made up ﹤0.01% of Allworth Financial's portfolio in Q2 2026, its #5116 holding.
- Allworth Financial first reported a position in Tenax Therapeutics in Q1 2024 and has held it in 10 quarters since.
- Allworth Financial's Tenax Therapeutics position peaked at $16 in Q1 2026.
- 111 funds tracked by Wall St. Rank held Tenax Therapeutics as of Q2 2026.
Based on Allworth Financial's 13F filing for Q2 2026, filed 11 Aug 2026.